Antidiabetic glucagon-likepeptide-1 agonists (also known as GLP-1 agonists) are a class of drugs used with a proper diet and exercise to control high blood sugar in people with type 2diabetes mellitus(T2DM) andobesity. T2DM is a long-term medical condition in which the body does not usei...
Seaport docks $225m for its improved neuropsychiatry drugs Novo joins Lilly in asking FDA for ban on GLP-1 compounding News Lexeo shares dip on early data with Alzheimer's gene therapy Lexeo Therapeutics' gene therapy for Alzheimer's has shown that it can reduce biomarkers of the disea...
MD, MB, ChB, professor at the University of Auckland, New Zealand, for the development of pharmacokinetic-pharmacodynamic (PKPD) models for the effects of drugs on the QT interval that are now being rediscovered by regulatory agencies trying to understand the safety consequences...